Hillhouse Capital Invests $35M Series A+ Round In Chinese Biopharmaceutical Firm Elpiscience
December 3, 2018 — 17:34 CST
This Data Is Locked!
This area is available only to Subscribers.
Chinese biotech company Elpiscience Biopharmaceuticals Co. has completed a US$35 million series A+ round of financing led by Hillhouse Capital, with participation from CDH Investments... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals